Phocas Financial Corp. Purchases New Position in MiMedx Group, Inc. (NASDAQ:MDXG)

Phocas Financial Corp. purchased a new stake in shares of MiMedx Group, Inc. (NASDAQ:MDXG) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 31,833 shares of the company’s stock, valued at approximately $306,000.

Several other institutional investors have also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC lifted its holdings in MiMedx Group by 1.0% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 183,021 shares of the company’s stock valued at $1,082,000 after purchasing an additional 1,822 shares during the last quarter. Disciplined Growth Investors Inc. MN lifted its holdings in MiMedx Group by 0.8% during the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 355,387 shares of the company’s stock valued at $2,100,000 after purchasing an additional 2,737 shares during the last quarter. SkyView Investment Advisors LLC lifted its holdings in MiMedx Group by 30.0% during the 3rd quarter. SkyView Investment Advisors LLC now owns 13,000 shares of the company’s stock valued at $77,000 after purchasing an additional 3,000 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in MiMedx Group by 6.3% during the 3rd quarter. Principal Financial Group Inc. now owns 55,495 shares of the company’s stock valued at $328,000 after purchasing an additional 3,292 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in MiMedx Group by 0.7% during the 4th quarter. Bank of New York Mellon Corp now owns 504,007 shares of the company’s stock valued at $4,849,000 after purchasing an additional 3,300 shares during the last quarter. 79.15% of the stock is owned by institutional investors.

MiMedx Group Trading Up 0.6 %

MDXG opened at $8.01 on Thursday. The company has a current ratio of 4.10, a quick ratio of 3.53 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $1.18 billion, a PE ratio of 14.56 and a beta of 1.94. MiMedx Group, Inc. has a 1-year low of $5.47 and a 1-year high of $10.14. The firm has a 50-day moving average price of $8.75 and a two-hundred day moving average price of $7.68.

MiMedx Group (NASDAQ:MDXG) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.07 earnings per share for the quarter, meeting the consensus estimate of $0.07. MiMedx Group had a net margin of 23.86% and a return on equity of 26.21%. As a group, equities analysts anticipate that MiMedx Group, Inc. will post 0.3 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, StockNews.com downgraded shares of MiMedx Group from a “strong-buy” rating to a “buy” rating in a report on Friday, November 8th. Six analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $12.00.

MiMedx Group Company Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.